Grant Supports Miniprotein Binder as Potential IPF Therapy

Grant Supports Miniprotein Binder as Potential IPF Therapy

299666

Grant Supports Miniprotein Binder as Potential IPF Therapy

The Washington Research Foundation (WRF) has awarded a $250,000 grant to support the development of a novel miniprotein binder to help treat idiopathic pulmonary fibrosis (IPF). The grant was awarded to Anindya Roy, PhD, an acting instructor and senior fellow at the University of Washington’s Institute for Protein Design (IPD). “The latest funding from WRF will enable us to reach several major milestones,” Roy said in a press release. The new grant will support research…

You must be logged in to read/download the full post.